KURA Kura Oncology, Inc. - Common Stock
$9,26
Fiyat · May 20, 2026
Temel veriler itibarıyla May 12, 2026
52 Haftlık Aralık
$5–$12
54% of range
Analist Derecelendirmesi
BUY
22 analysts
Fiyat Hedefi
$31
+237% upside
P/E (TTM)
-3.3
ROE
-116.2%
Net Kâr Marjı
-413.0%
KURA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$9.26
Piyasa Değeri
$913M
P/E (TTM)
-3.3
EPS (TTM)
$-3.18
Gelir (TTM)
$67M
Temettü Verimi
—
ROE
-116.2%
D/E Borç/Özsermaye
0.1
52 Haftlık Aralık
$5 – $12
KURA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$67M
2023-12-31
→
2025-12-31
Hisse Başına Kâr
$-3.18
2020-12-31
→
2025-12-31
Serbest Nakit Akışı
$-71M
2020-12-31
→
2025-12-31
Marjlar
-413.0%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
KURA
Akran Ortalaması
P/E (TTM)
-3.3
157.3
P/S (TTM) (F/S (TTM))
13.5
10.1
P/B (F/D)
5.2
3.4
EV / EBITDA
-2.5
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-12.9
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
KURA
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-449.9%
—
Net Profit Margin (Net Kâr Marjı)
-413.0%
-192.8%
ROA
-37.2%
-41.8%
ROE
-116.2%
-77.8%
ROIC
-165.3%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
KURA
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.1
2.0
Current Ratio (Cari Oran)
6.1
5.7
Quick Ratio (Cari Oran)
1.3
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
KURA
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
25.2%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
KURA
Akran Ortalaması
KURA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
22 analist
- Güçlü Al 6 27,3%
- Al 13 59,1%
- Tut 3 13,6%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
12 analist · 2026-05-20
Medyan
$28.00
← Tüm hedeflerin altında
$9.26
Düşük
$15.00
Yüksek
$76.00
Medyan hedef
$28.00
+202,4%
Ortalama hedef
$31.17
+236,6%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.23%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.83 | $-0.65 | -0.18% |
| 31 Aralık 2025 | $-0.92 | $-0.49 | -0.43% |
| 30 Eylül 2025 | $-0.85 | $-0.87 | 0.02% |
| 30 Haziran 2025 | $-0.75 | $-0.47 | -0.28% |
| 31 Mart 2025 | $-0.66 | $-0.40 | -0.26% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| CGEM | $624M | -3.2 | — | — | -44.0% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | — |
| AVTX | $336M | -3.1 | -86.6% | -132642.4% | -83.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| ORIC | $806M | -5.6 | — | — | -36.5% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 15
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $67M | $54M | $0 | |
| R&D Expense | $251M | $170M | $115M | |
| SG&A Expense | $120M | $77M | $51M | |
| Operating Expenses | $371M | $247M | $166M | |
| Operating Income | $-304M | $-193M | $-166M | |
| Interest Expense | · | · | $2M | |
| Other Non-op | $25M | $21M | $13M | |
| Pretax Income | $-278M | $-172M | $-153M | |
| Income Tax | $297.0K | $2M | $0 | |
| Net Income | $-279M | $-174M | $-153M | |
| EPS (Basic) | $-3.18 | $-2.02 | $-2.08 | |
| EPS (Diluted) | $-3.18 | $-2.02 | $-2.08 | |
| Shares (Basic) | 87,676,000 | 86,161,000 | 73,229,000 | |
| Shares (Diluted) | 87,676,000 | 86,161,000 | 73,229,000 | |
| EBITDA | $-304M | $-193M | · |
Bilanço 23
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $149M | $224M | $37M | |
| Receivables | $9M | $2M | · | |
| Inventory | $413.0K | $0 | · | |
| Prepaid Expense | $32M | $15M | $9M | |
| Current Assets | $709M | $745M | $432M | |
| PP&E (Net) | $8M | $2M | $2M | |
| PP&E (Gross) | $11M | $5M | $4M | |
| Accum. Depreciation | $3M | $3M | $2M | |
| Other Non-current Assets | $15M | $8M | $8M | |
| Total Assets | $738M | $760M | $449M | |
| Accounts Payable | $5M | $1M | $2M | |
| Current Liabilities | $117M | $79M | $35M | |
| Capital Leases | $9M | $5M | $6M | |
| Other Non-current Liabilities | $3M | $2M | $705.0K | |
| Total Liabilities | $564M | $347M | $52M | |
| Long-term Debt | $10M | $10M | · | |
| Total Debt | $10M | $10M | $9M | |
| Common Stock | $9.0K | $8.0K | $7.0K | |
| Retained Earnings | $-1.17B | $-895M | $-721M | |
| AOCI | $1M | $764.0K | $-1M | |
| Stockholders' Equity | $174M | $414M | $397M | |
| Liabilities + Equity | $738M | $760M | $449M | |
| Shares Outstanding | 87,855,000 | 78,229,000 | 74,350,000 |
Nakit Akışı 8
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $37M | $34M | $28M | |
| Operating Cash Flow | $-64M | $134M | $-125M | |
| CapEx | $7M | $472.0K | $168.0K | |
| Investing Cash Flow | $-13M | $-102M | $16M | |
| Financing Cash Flow | $2M | $154M | $95M | |
| Net Change in Cash | $-75M | $187M | $-14M | |
| Taxes Paid | $2M | · | · | |
| Free Cash Flow | $-71M | $134M | $-125M |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -449.9% | -358.6% | · | |
| Net Margin | -413.0% | -322.9% | · | |
| Pretax Margin | -412.5% | -319.1% | · | |
| EBITDA Margin | -449.9% | -358.6% | · | |
| ROA | -37.2% | -28.8% | -33.7% | |
| ROE | -116.2% | -41.5% | -36.9% | |
| ROIC | -165.3% | -46.2% | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 6.1 | 9.5 | 12.3 | |
| Quick Ratio | 1.3 | 2.9 | 1.1 | |
| Debt / Equity | 0.1 | 0.0 | 0.0 | |
| LT Debt / Equity | 0.1 | 0.0 | 0.0 |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | |
| Receivables Turnover | 12.4 | · | · |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 25.2% | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $67M | $54M | $0 | |
| Net Income TTM | $-279M | $-174M | $-153M | |
| Market Cap | $913M | $681M | $1.07B | |
| Enterprise Value | $773M | $466M | $1.04B | |
| P/E | -3.3 | -4.3 | -6.9 | |
| P/S | 13.5 | 12.6 | · | |
| P/B | 5.2 | 1.6 | 2.7 | |
| P / Tangible Book | 5.2 | 1.6 | 2.7 | |
| P / Cash Flow | -14.2 | 5.1 | -8.6 | |
| P / FCF | -12.9 | 5.1 | -8.6 | |
| EV / EBITDA | -2.5 | -2.4 | · | |
| EV / FCF | -10.9 | 3.5 | -8.3 | |
| EV / Revenue | 11.5 | 8.7 | · | |
| Earnings Yield | -30.6% | -23.2% | -14.5% |
Gelir Tablosu 15
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $18M | $17M | $21M | $15M | $14M | |
| Cost of Revenue | $262.0K | · | · | · | · | |
| R&D Expense | $65M | $64M | $68M | $63M | $56M | |
| SG&A Expense | $32M | $39M | $33M | $25M | $23M | |
| Operating Expenses | $97M | $104M | $101M | $88M | $79M | |
| Operating Income | $-79M | $-86M | $-80M | $-73M | $-65M | |
| Other Non-op | $5M | $5M | $6M | $7M | $7M | |
| Pretax Income | $-73M | $-81M | $-74M | $-66M | $-57M | |
| Income Tax | $8.0K | $71.0K | $0 | $0 | $226.0K | |
| Net Income | $-73M | $-81M | $-74M | $-66M | $-57M | |
| EPS (Basic) | $-0.83 | $-0.92 | $-0.85 | $-0.75 | $-0.66 | |
| EPS (Diluted) | $-0.83 | $-0.92 | $-0.85 | $-0.75 | $-0.66 | |
| Shares (Basic) | 88,610,000 | -174,970,000 | 87,645,000 | 87,586,000 | 87,415,000 | |
| Shares (Diluted) | 88,610,000 | -174,970,000 | 87,645,000 | 87,586,000 | 87,415,000 | |
| EBITDA | $-79M | · | $-80M | $-73M | $-65M |
Bilanço 23
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $39M | $149M | $95M | $82M | $51M | |
| Receivables | $9M | $9M | $36M | $5M | $49M | |
| Inventory | $843.0K | $413.0K | · | · | · | |
| Prepaid Expense | $33M | $32M | $35M | $25M | $17M | |
| Current Assets | $624M | $709M | $621M | $660M | $724M | |
| PP&E (Net) | $8M | $8M | $7M | $4M | $2M | |
| PP&E (Gross) | $11M | $11M | $11M | $8M | $6M | |
| Accum. Depreciation | $3M | $3M | $4M | $4M | $4M | |
| Other Non-current Assets | $14M | $15M | $14M | $11M | $9M | |
| Total Assets | $653M | $738M | $649M | $682M | $744M | |
| Accounts Payable | $7M | $5M | $5M | $2M | $5M | |
| Current Liabilities | $101M | $117M | $121M | $107M | $90M | |
| Capital Leases | $13M | $9M | $8M | $8M | $8M | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $2M | |
| Total Liabilities | $545M | $564M | $407M | $377M | $379M | |
| Long-term Debt | · | $10M | $10M | $10M | $10M | |
| Total Debt | $10M | · | $10M | $10M | $10M | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | |
| Retained Earnings | $-1.25B | $-1.17B | $-1.09B | $-1.02B | $-953M | |
| AOCI | · | $1M | · | $711.0K | $974.0K | |
| Stockholders' Equity | $108M | $174M | $243M | $305M | $364M | |
| Liabilities + Equity | $653M | $738M | $649M | $682M | $744M | |
| Shares Outstanding | 88,763,000 | 87,855,000 | 87,016,000 | 86,797,000 | 80,778,000 |
Nakit Akışı 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $11M | $11M | $7M | $8M | |
| Operating Cash Flow | $-86M | $117M | $-81M | $-29M | $-72M | |
| CapEx | $128.0K | $2M | $3M | $1M | $292.0K | |
| Investing Cash Flow | $-24M | $-65M | $94M | $59M | $-101M | |
| Financing Cash Flow | $69.0K | $1M | $0 | $515.0K | $143.0K | |
| Net Change in Cash | $-110M | $54M | $13M | $31M | $-173M | |
| Free Cash Flow | $-86M | · | · | · | $-72M |
Kârlılık 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating Margin | -431.5% | · | -385.5% | -475.3% | -458.6% | |
| Net Margin | -401.5% | · | -357.2% | -432.5% | -407.1% | |
| Pretax Margin | -401.4% | · | -357.2% | -432.5% | -405.5% | |
| EBITDA Margin | -431.5% | · | -385.5% | -475.3% | -458.6% | |
| ROA | -10.5% | · | -13.1% | -11.0% | -8.8% | |
| ROE | -31.1% | · | -22.2% | -17.1% | -13.2% | |
| ROIC | -67.0% | · | · | · | -17.4% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | · | 5.1 | 6.2 | 8.1 | |
| Quick Ratio | 0.5 | · | 1.1 | 0.8 | 1.1 | |
| Debt / Equity | 0.1 | · | 0.0 | 0.0 | 0.0 | |
| LT Debt / Equity | 0.1 | · | 0.0 | 0.0 | 0.0 |
Verimlilik 3
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.6 | · | · | · | · | |
| Receivables Turnover | 0.6 | · | 1.2 | 6.7 | 0.6 |
Değerleme (TTM) 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue TTM | $68M | · | · | · | · | |
| Net Income TTM | $-271M | · | $-252M | $-229M | $-212M | |
| Market Cap | $722M | · | $770M | $501M | $533M | |
| Enterprise Value | $692M | · | $684M | $428M | $491M | |
| P/E | -2.6 | · | -3.1 | -2.2 | -2.7 | |
| P/S | 10.5 | · | · | · | · | |
| P/B | 6.7 | · | 3.2 | 1.6 | 1.5 | |
| P / Tangible Book | 6.7 | · | 3.2 | 1.6 | 1.5 | |
| P / Cash Flow | -8.4 | · | · | · | -7.4 | |
| P / FCF | -8.4 | · | · | · | -7.4 | |
| EV / EBITDA | -8.8 | · | -8.6 | -5.9 | -7.6 | |
| EV / FCF | -8.1 | · | · | · | -6.8 | |
| EV / Revenue | 10.1 | · | · | · | · | |
| Earnings Yield | -38.0% | · | -32.7% | -45.6% | -37.4% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $67M | $54M | $0 | — | — |
| Faaliyet Kâr Marjı % | -449.9% | -358.6% | — | — | — |
| Net Gelir | $-279M | $-174M | $-153M | $-136M | $-130M |
| Seyreltilmiş Hisse Başı Kâr | $-3.18 | $-2.02 | $-2.08 | $-2.03 | $-1.97 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.1 | 0.0 | 0.0 | 0.0 | — |
| Cari Oran | 6.1 | 9.5 | 12.3 | 18.6 | 23.3 |
| Cari Oran | 1.3 | 2.9 | 1.1 | 2.2 | 4.0 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-71M | $134M | $-125M | $-111M | $-106M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.